Novo Nordisk

Use of diabetes and anti-obesity drugs surges nationwide
Axios
Fri, 01/3/25 - 10:07 am
obesity
diabetes
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Mounjaro
Zepbound
GLP-1 agonist
10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
clinical trials
Eli Lilly
cardiovascular disease
Arvinas
protein degradation
Vera Therapeutics
IgA nephropathy
Novarts
pelacarsen
Entyvio
IBD
Novo Nordisk
Alzheimer's disease
Beam Therapeutics
sickle cell disease
COMPASS Pathways
psychedelics
Moderna Therapeutics
Verve Therapeutics
high cholesterol
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
BioPharma Dive
Thu, 01/2/25 - 11:35 am
FDA
Vertex Pharmaceuticals
Novo Nordisk
Bristol Myers Squibb
Alyftrek
cystic fibrosis
Alhemo
hemophilia
Opdivo Qvantiq
solid tumors
Novo’s next-gen obesity drug misses expectations in closely watched trial
BioPharma Dive
Fri, 12/20/24 - 11:34 am
Novo Nordisk
CagriSema
clinical trials
weight loss
Novo Nordisk taps Photys for $186M cardiometabolic collab
Fierce Biotech
Wed, 12/18/24 - 11:21 am
Novo Nordisk
Photys
MASH
chronic kidney disease
A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss
Pharmaphorum
Wed, 12/18/24 - 11:14 am
patients
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Novo Nordisk blueprints $1.2B rare disease production plant in Denmark, where it plans to hire on 400 new staffers
Fierce Pharma
Mon, 12/16/24 - 11:44 am
Novo Nordisk
Denmark
drug manufacturing
Novo Nordisk's Ozempic reportedly linked to vision loss in new study
Yahoo Finance
Mon, 12/16/24 - 11:39 am
Novo Nordisk
Ozempic
vision loss
UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy
Yahoo/Reuters
Fri, 12/13/24 - 11:43 am
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
UK
obesity
Novo Nordisk slashes prices of additional insulin products but not until 2026
Fierce Pharma
Sun, 12/8/24 - 09:42 pm
Novo Nordisk
insulin
diabetes
drug pricing
Novo Nordisk to cut US list prices of two insulin products by more than 70%
MSN/Reuters
Thu, 12/5/24 - 04:14 pm
Novo Nordisk
drug pricing
insulin
Fiasp
Tresiba
diabetes
Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark
Fierce Pharma
Thu, 12/5/24 - 11:17 am
Novo Nordisk
Denmark
drug manufacturing
Antag, a startup backed by Versant and Novo, joins hunt for obesity drug alternatives
BioPharma Dive
Wed, 12/4/24 - 11:15 pm
Antag Therapeutics
Versant
Novo Nordisk
obesity
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
Yahoo/Reuters
Wed, 12/4/24 - 11:08 am
Novavax
Novo Nordisk
czech republic
drug manufacturing
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial
BioPharma Dive
Wed, 12/4/24 - 11:02 am
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
weight loss
obesity
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Pharma Live
Tue, 12/3/24 - 11:36 am
Novo Nordisk
India
Wegovy
Eli Lilly
Zepbound
Four oral GLP-1R products in Phase III trials as race intensifies
Clinical Trials Arena
Tue, 12/3/24 - 11:17 am
Novo Nordisk
Eli Lilly
Jiangsu Hengrui
GLP-1R
GLP-1 agonists
clinical trials
Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
MSN
Wed, 11/27/24 - 09:57 pm
Novo Nordisk
Wegovy
Canada
Health Canada
obesity
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Joe Biden
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Zepbound
Wegovy
Ozempic
Pfizer led industrywide sales surge in Q3 after several quarters of dominance by Eli Lilly, Novo Nordisk
Fierce Pharma
Mon, 11/25/24 - 11:43 am
Pfizer
earnings
Eli Lilly
Novo Nordisk

Pages